<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02471170</url>
  </required_header>
  <id_info>
    <org_study_id>UPCC 02215</org_study_id>
    <nct_id>NCT02471170</nct_id>
  </id_info>
  <brief_title>Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases</brief_title>
  <official_title>Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abramson Cancer Center of the University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abramson Cancer Center of the University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect blood samples to detect potential markers of&#xD;
      pancreatic cancer in the blood and link these findings to medical and health information.&#xD;
      Information from this study may help to provide insight into the detection of pancreas cancer&#xD;
      in the blood before it can be found by other methods or provide a method of monitoring the&#xD;
      status of pancreatic cancer throughout a treatment course. Another purpose of this study is&#xD;
      to collect blood to create a biobank.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 10, 2015</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Collection of blood and tissue samples from subjects with pancreatic diseases</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pancreatic Diseases</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The frequency of research blood collection will not exceed 60 mL in a 1 week period and will&#xD;
      not occur more frequently than 4 times in an 8 week period.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        subjects with pancreatic diseases&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The subject must be a patient at the Hospital of the University of Pennsylvania&#xD;
&#xD;
               -  The subject must be under evaluation and/or treatment for a pancreatic disease&#xD;
&#xD;
               -  The subject must be under evaluation and/or treatment for a non-pancreatic&#xD;
                  disease. For example, patients undergoing routine colonoscopy within the clinical&#xD;
                  practice will be asked to consent to provide control samples.&#xD;
&#xD;
          2. The subject must be able to provide informed consent or have an acceptable surrogate&#xD;
             capable of giving consent on the subject's behalf&#xD;
&#xD;
          3. The subject must be 18 years of age or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. The subject or acceptable surrogate does not provide informed consent&#xD;
&#xD;
          2. Subject is a prisoner&#xD;
&#xD;
          3. Subject is under 18 years of age&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter O'Dwyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Abramson Cancer Center of the University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Abramson Cancer Center of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 11, 2015</study_first_submitted>
  <study_first_submitted_qc>June 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2015</study_first_posted>
  <last_update_submitted>April 28, 2021</last_update_submitted>
  <last_update_submitted_qc>April 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

